Some continue longer under a providers care, while others taper off once theyve built sustainable habits
My best guess is some sort of activation of the RAAS system is happening to lower blood pressure along with the increase in urination seen with GLP-1 medications
Caloric Expenditure : Studies indicate that GLP-1 may increase energy expenditure by promoting the utilization of calories, thereby assisting in weight loss efforts
Audio on npr.org may be edited after its original broadcast or publication
The Food and Drug Administration on Friday said it would reconsider its decision to remove Eli Lillys tirzepatide, sold as Mounjaro for diabetes and Zepbound for obesity, from its shortage list, and, for the time being, would not pursue regulatory action against certain compounding pharmacies making copies of the drugs
It's how you catch a rise while it's still small